Does TORIPALIMAB Cause Decreased appetite? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Decreased appetite have been filed in association with TORIPALIMAB (LOQTORZI). This represents 3.2% of all adverse event reports for TORIPALIMAB.
43
Reports of Decreased appetite with TORIPALIMAB
3.2%
of all TORIPALIMAB reports
9
Deaths
9
Hospitalizations
How Dangerous Is Decreased appetite From TORIPALIMAB?
Of the 43 reports, 9 (20.9%) resulted in death, 9 (20.9%) required hospitalization, and 3 (7.0%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for TORIPALIMAB.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
Off label use (276)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which TORIPALIMAB Alternatives Have Lower Decreased appetite Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN